Skip Navigation

European Heart Journal 1997 18(Supplement D):124-129; doi:10.1093/eurheartj/18.suppl_D.124
Copyright © 1997 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bax, J.J.
Right arrow Articles by Fioretti, P. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bax, J.J.
Right arrow Articles by Fioretti, P. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1997 The European Society of Cardiology

FDG SPECT in the assessment of myocardial viability

Comparison with dobutamine echo

J.J. Bax*, R. Valkema{dagger}, F. C. Visser{ddagger}, A. van Lingen§, J. H. Cornel, D. Poldermans||, R. Rambaldi**, E. P. Krenning{dagger} and P. M. Fioretti**,

* Department of Cardiology, University Hospital Leiden The Netherlands
{dagger} Department of Nuclear Medicine, University Hospital Rotterdam The Netherlands
{ddagger} Department of Cardiology, Free University Hospital Amsterdam The Netherlands
§ Department of Nuclear Medicine, Free University Hospital Amsterdam The Netherlands
¶ Department of Cardiology, Medical Center Alkmaar The Netherlands
|| Department of Surgery, University Hospital Rotterdam The Netherlands
** Department of Cardiology, University Hospital Rotterdam The Netherlands

Correspondence: Dr P. M. Fioretti, University Hospital Dijkzigt, Department of Cardiology, Ba 300, Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands

The use of 18F-fluorodeoxyglucose (FDG) imaging with single photon emission computed tomography (SPECT) has been introduced recently to assess myocardial viability. Several centres have now gained experience with cardiac FDG SPECT imaging, and this report is a summary of the currently available FDG SPECT data. Three studies have compared FDG SPECT with FDG positron emission tomography and demonstrated good agreement between them. Initial results in patients undergoing revascularization suggest that FDG SPECT can predict improvement in contractile function after revascularization. Although the initial results are promising, larger studies are needed to determine the precise role of FDG SPECT in the assessment of myocardial viability.

Key Words: 18F-flourodeoxyglucose • single photon emission computed tomography • myocardial viability


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.